The 2026 Global Medtech Contract Development and Manufacturing Report
Alira Health in collaboration with MassMEDIC
The global medtech CDMO market is entering a new phase defined by consolidation, capability expansion, and accelerating pharma-medtech convergence, and is projected to reach $143.6B by 2030 at an 8.3% CAGR.
Alira Health’s 2026 Global Medtech Contract Development and Manufacturing Report examines how this shift is reshaping the competitive landscape and where CDMOs are investing to keep pace.
The report analyzes the key trends shaping outsourcing strategies, deal activity, and capability development across the industry, supported by a global CDMO census, market analysis, and expert interviews.
What you’ll learn:
- Where growth is concentrating: Drug delivery systems reach $15.2B and lead market expansion (9.1% CAGR through 2030).
- How consolidation is evolving: 54 deals in 2025, with increasing focus on pharma-medtech integration.
- Why pharma-medtech convergence matters right now: CDMOs expanding into fill-finish and formulation to support integrated drug-device delivery. Surge in investments across micro-molding, sterile packaging, and precision machining.
Fill out the form to download “The 2026 Global Medtech Contract Development and Manufacturing Report.”
Questions about the medtech CDMO market? Reach out to our Center of Excellence at [email protected].
The 2026 Global Medtech Contract Development and Manufacturing Report
Alira Health in collaboration with MassMEDIC
The global medtech CDMO market is entering a new phase defined by consolidation, capability expansion, and accelerating pharma-medtech convergence, and is projected to reach $143.6B by 2030 at an 8.3% CAGR.
Alira Health’s 2026 Global Medtech Contract Development and Manufacturing Report examines how this shift is reshaping the competitive landscape and where CDMOs are investing to keep pace.
The report analyzes the key trends shaping outsourcing strategies, deal activity, and capability development across the industry, supported by a global CDMO census, market analysis, and expert interviews.
Fill out the form to download “The 2026 Global Medtech Contract Development and Manufacturing Report.”
What you’ll learn:
- Where growth is concentrating: Drug delivery systems reach $15.2B and lead market expansion (9.1% CAGR).
- How consolidation is evolving: 54 deals in 2025, with increasing focus on pharma-medtech integration.
- Which capabilities are winning: Surge in investments across micro-molding, sterile packaging, and precision machining.
- Why pharma-medtech convergence matters right now: CDMOs expanding into fill-finish and formulation to support integrated drug-device delivery. Surge in investments across micro-molding, sterile packaging, and precision machining.
Subscribe to our newsletter for the latest news, events, and thought leadership